Attività Correnti Cambiamento Data
AbbVie USD 37.48B 3.81B 2026-09
Alcon AG USD 6.62B 4M 2026-06
Almirall EUR 747.1M 33.12M 2026-06
Amgen USD 34.36B 598M 2026-09
argenx SE USD 8.07B 1.17B 2026-06
AstraZeneca USD 31.45B 3.48B 2026-09
Autolus Therapeutics Ltd USD 366.78M 30.69M 2026-09
Bayer EUR 39.6B 5.96B 2026-09
Biogen USD 7.58B 278.7M 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Eli Lilly USD 65.26B 591M 2026-09
Fresenius EUR 12.29B 678M 2026-09
Fresenius Medical Care EUR 7.84B 150.6M 2026-09
Genmab DKK 2.8B 228M 2026-06
Gilead Sciences USD 16.55B 4.02B 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
GRIFOLS EUR 5.35B 40M 2026-09
Haleon GBP 4.55B 406M 2025-12
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Lakefront Biotherapeutics EUR 2.31B 751.38M 2026-06
Lonza CHF 8B 3.41B 2025-12
Merck EUR 15.14B 1.37B 2026-09
Merck USD 38.94B 2.26B 2026-09
Novartis USD 28.75B 1.4B 2026-09
Orion EUR 1.34B 139.5M 2026-09
Pfizer USD 45.01B 3.65B 2026-09
Philips EUR 10.51B 1.18B 2026-09
Recordati EUR 1.89B 128.35M 2026-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 33.21B 1.68B 2026-09
UCB EUR 6.05B 733M 2025-12